Treatment of severe drug reactions by hemodialysis

Rokea A. el-Azhary, Michael Z. Wang, Ashley B. Wentworth, LaTonya Hickson

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Extracorporeal treatments such as hemodialysis and plasma exchange are lifesaving measures in the treatment of drug poisoning. This treatment method generally is not used for severe cutaneous and systemic drug reactions. Methods: Here, we describe three cases wherein hemodialysis therapy was instrumental in reversing the adverse drug reaction. Results: In the cases of severe cutaneous drug reactions reviewed, patients presented with linear immunoglobulin A bullous dermatosis, acute generalized exanthematous pustulosis, and toxic epidermal necrolysis. Salvage treatment with hemodialysis therapy drastically influenced the course of disease, resulting in remission. Conclusions: This novel and highly effective treatment option is not considered in current algorithms for adverse drug reactions. Hence, in addition to the rarity of these reactions, the main limitation of the study is the small number of patients. Hemodialysis can substantially alter the prognosis and, in some cases, be a lifesaving treatment for patients with severe adverse cutaneous drug reaction associated with systemic toxicity.

Original languageEnglish (US)
Pages (from-to)177-182
Number of pages6
JournalInternational Journal of Dermatology
Volume57
Issue number2
DOIs
StatePublished - Feb 1 2018

Fingerprint

Renal Dialysis
Pharmaceutical Preparations
Drug-Related Side Effects and Adverse Reactions
Skin
Therapeutics
Acute Generalized Exanthematous Pustulosis
Vesiculobullous Skin Diseases
Salvage Therapy
Stevens-Johnson Syndrome
Plasma Exchange
Poisoning
Immunoglobulin A

ASJC Scopus subject areas

  • Dermatology

Cite this

Treatment of severe drug reactions by hemodialysis. / el-Azhary, Rokea A.; Wang, Michael Z.; Wentworth, Ashley B.; Hickson, LaTonya.

In: International Journal of Dermatology, Vol. 57, No. 2, 01.02.2018, p. 177-182.

Research output: Contribution to journalArticle

el-Azhary, Rokea A. ; Wang, Michael Z. ; Wentworth, Ashley B. ; Hickson, LaTonya. / Treatment of severe drug reactions by hemodialysis. In: International Journal of Dermatology. 2018 ; Vol. 57, No. 2. pp. 177-182.
@article{cd9974cc2fcd419bb556b2f2c0c1d188,
title = "Treatment of severe drug reactions by hemodialysis",
abstract = "Background: Extracorporeal treatments such as hemodialysis and plasma exchange are lifesaving measures in the treatment of drug poisoning. This treatment method generally is not used for severe cutaneous and systemic drug reactions. Methods: Here, we describe three cases wherein hemodialysis therapy was instrumental in reversing the adverse drug reaction. Results: In the cases of severe cutaneous drug reactions reviewed, patients presented with linear immunoglobulin A bullous dermatosis, acute generalized exanthematous pustulosis, and toxic epidermal necrolysis. Salvage treatment with hemodialysis therapy drastically influenced the course of disease, resulting in remission. Conclusions: This novel and highly effective treatment option is not considered in current algorithms for adverse drug reactions. Hence, in addition to the rarity of these reactions, the main limitation of the study is the small number of patients. Hemodialysis can substantially alter the prognosis and, in some cases, be a lifesaving treatment for patients with severe adverse cutaneous drug reaction associated with systemic toxicity.",
author = "el-Azhary, {Rokea A.} and Wang, {Michael Z.} and Wentworth, {Ashley B.} and LaTonya Hickson",
year = "2018",
month = "2",
day = "1",
doi = "10.1111/ijd.13837",
language = "English (US)",
volume = "57",
pages = "177--182",
journal = "International Journal of Dermatology",
issn = "0011-9059",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Treatment of severe drug reactions by hemodialysis

AU - el-Azhary, Rokea A.

AU - Wang, Michael Z.

AU - Wentworth, Ashley B.

AU - Hickson, LaTonya

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Background: Extracorporeal treatments such as hemodialysis and plasma exchange are lifesaving measures in the treatment of drug poisoning. This treatment method generally is not used for severe cutaneous and systemic drug reactions. Methods: Here, we describe three cases wherein hemodialysis therapy was instrumental in reversing the adverse drug reaction. Results: In the cases of severe cutaneous drug reactions reviewed, patients presented with linear immunoglobulin A bullous dermatosis, acute generalized exanthematous pustulosis, and toxic epidermal necrolysis. Salvage treatment with hemodialysis therapy drastically influenced the course of disease, resulting in remission. Conclusions: This novel and highly effective treatment option is not considered in current algorithms for adverse drug reactions. Hence, in addition to the rarity of these reactions, the main limitation of the study is the small number of patients. Hemodialysis can substantially alter the prognosis and, in some cases, be a lifesaving treatment for patients with severe adverse cutaneous drug reaction associated with systemic toxicity.

AB - Background: Extracorporeal treatments such as hemodialysis and plasma exchange are lifesaving measures in the treatment of drug poisoning. This treatment method generally is not used for severe cutaneous and systemic drug reactions. Methods: Here, we describe three cases wherein hemodialysis therapy was instrumental in reversing the adverse drug reaction. Results: In the cases of severe cutaneous drug reactions reviewed, patients presented with linear immunoglobulin A bullous dermatosis, acute generalized exanthematous pustulosis, and toxic epidermal necrolysis. Salvage treatment with hemodialysis therapy drastically influenced the course of disease, resulting in remission. Conclusions: This novel and highly effective treatment option is not considered in current algorithms for adverse drug reactions. Hence, in addition to the rarity of these reactions, the main limitation of the study is the small number of patients. Hemodialysis can substantially alter the prognosis and, in some cases, be a lifesaving treatment for patients with severe adverse cutaneous drug reaction associated with systemic toxicity.

UR - http://www.scopus.com/inward/record.url?scp=85034776895&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034776895&partnerID=8YFLogxK

U2 - 10.1111/ijd.13837

DO - 10.1111/ijd.13837

M3 - Article

VL - 57

SP - 177

EP - 182

JO - International Journal of Dermatology

JF - International Journal of Dermatology

SN - 0011-9059

IS - 2

ER -